Regulatory Eli Lilly wins FDA approval for weight loss pill, tees up Novo rivalry Pharmaceutical TechnologyLilly's product, known under the brand name Foundayo, has a clear route to early blockbuster status.RegulatoryMetabolic & GLP-1Read full story pharminent April 2, 2026 (Last updated: April 2, 2026) Pharmaceutical Technology Lilly’s product, known under the brand name Foundayo, has a clear route to early blockbuster status. RegulatoryMetabolic & GLP-1Read full story Post navigation Previous: Building What’s Next: Join Industry Leaders to Shape Access and Affordability Trends Ahead of Asembia AXS26Next: ACC 2026: Meta-analysis supports CagriSema as superior first-line therapy in obesity Related Stories Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026 Regulatory HHS appoints permanent FDA CBER, CDER heads pharminent September 10, 2026 Regulatory FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer pharminent September 7, 2026